Continental Chemicals Reports No Fund Utilization Deviation

Continental Chemicals Limited has submitted a regulatory compliance filing to the Bombay Stock Exchange pursuant to Regulation 32 of SEBI (LODR) Regulations, 2015. The filing is a Statement of Deviation and Variation of utilization of funds raised through preferential issue for the quarter ended 30th June, 2026.

Key Details:

Mode of Fund Raising: Preferential Issues
Date of Raising Funds: 14/10/2019
Amount Raised: ₹1,62,50,000 (₹1.63 crore)
Monitoring Agency: Not Applicable
Deviation/Variation in Use of Funds: No
Shareholder Approval Requirement: Not Applicable
Explanation for Deviation: Not Applicable
Audit Committee Comments: Reviewed and Approved by audit committee
Auditors Comments: Not Applicable

Fund Utilization Details:

Original Object: Company has required the funds for working capital
Modified Object: Not Applicable
Original Allocation: ₹1,62,50,000
Modified Allocation: Not Applicable
Funds Utilized: Fully utilized
Amount of Deviation/Variation for the quarter: ₹0

Important Note:

The funds have been fully utilized in the quarter ended 31/12/2023. The company confirms no deviation or variation in the use of funds, meaning:

(a) No deviation in the objects or purposes for which the funds were raised

(b) No deviation in the amount of funds actually utilized as against originally disclosed